Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth
Juliana H. Azambuja, Nicolly Espindola Gelsleichter, Liziane Raquel Beckenkamp, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 5, pp. 3260-3279
Closed Access | Times Cited: 84

Showing 26-50 of 84 citing articles:

MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2
Chao Yang, Haoqiang Zhan, Yiqing Zhao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer
Ryan R. Kowash, Esra A. Akbay
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders
Matteo Battaglini, Attilio Marino, Margherita Montorsi, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 12
Closed Access | Times Cited: 11
CD73 Molecule Inhibitor Upregulates miR16 Expression in Experimental Glioblastoma and Inhibits Angiogenesis by Targeting VEGF
Samaneh Arab, Sahar Ghasemi, Marjan Bahraminasab, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 2
Open Access
Acyclic purine and pyrimidine nucleotide analogs as ecto-5’-nucleotidase (CD73) inhibitors
Stephanie Federico, Christian Renn, Petra Břehová, et al.
European Journal of Medicinal Chemistry (2025), pp. 117653-117653
Open Access
Tannic acid elicits selective antitumoral activity in vitro and inhibits cancer cell growth in a preclinical model of glioblastoma multiforme
Natália Pontes Bona, Nathália Stark Pedra, Juliana H. Azambuja, et al.
Metabolic Brain Disease (2019) Vol. 35, Iss. 2, pp. 283-293
Closed Access | Times Cited: 34
Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds
Mingxue Zhang, Xiaoqin Dai, Yu Xiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115546-115546
Closed Access | Times Cited: 10
Dietary adenosine supplementation improves placental angiogenesis in IUGR piglets by up-regulating adenosine A2a receptor
Zifang Wu, Jiawei Nie, Deyuan Wu, et al.
Animal nutrition (2023) Vol. 13, pp. 282-288
Open Access | Times Cited: 9
Antitumoral Activity of Cecropia Pachystachya Leaves Extract in Vitro and in Vivo Model of Rat Glioma: Brain and Blood Effects
Natália Pontes Bona, Nathália Stark Pedra, Luíza Spohr, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8234-8252
Closed Access | Times Cited: 3
Boost Infiltration and Activity of T Cells via Inhibiting Ecto-5′-nucleotidase (CD73) Immune Checkpoint to Enhance Glioblastoma Immunotherapy
Hao Zhang, Yang Li, Mengxiao Han, et al.
ACS Nano (2024) Vol. 18, Iss. 34, pp. 23001-23013
Closed Access | Times Cited: 3
CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model
Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, et al.
Cancer Chemotherapy and Pharmacology (2020) Vol. 85, Iss. 6, pp. 1177-1182
Closed Access | Times Cited: 27
Modulation of Blood–Brain Barrier Permeability by Activating Adenosine A2 Receptors in Oncological Treatment
Kamila Wala, Wojciech Szlasa, Jolanta Saczko, et al.
Biomolecules (2021) Vol. 11, Iss. 5, pp. 633-633
Open Access | Times Cited: 23
The crossroads of adenosinergic pathway and epithelial-mesenchymal plasticity in cancer
Isabele Cristiana Iser, Samlai Vedovatto, Fernanda Dittrich Oliveira, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 202-213
Closed Access | Times Cited: 15
CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer
Lu Cao, Kim R. Bridle, Ritu Shrestha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1565-1565
Open Access | Times Cited: 14
Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
Xin-Qi Teng, Jian Qu, Guohua Li, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 14
Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes
Gabriela Nogueira Debom, Dominique S. Rubenich, Elizandra Braganhol
Frontiers in Neuroscience (2022) Vol. 15
Open Access | Times Cited: 13
Colorectal Cancer and Purinergic Signalling: An Overview
Gabriela Gonçalves Roliano, Juliana H. Azambuja, Veronica Brunetto, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4887-4887
Open Access | Times Cited: 13
CD73 in glioblastoma: Where are we now and what are the future directions?
Nicolly Espindola Gelsleichter, Juliana H. Azambuja, Dominique S. Rubenich, et al.
Immunology Letters (2023) Vol. 256-257, pp. 20-27
Closed Access | Times Cited: 7
Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial–Mesenchymal Transition-Like Reprogramming
Julia Tsiampali, Silke Neumann, Beatriz Giesen, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 378-378
Open Access | Times Cited: 19
Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma
Ketao Jin, Chunsen Mao, Lin Chen, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 229-229
Open Access | Times Cited: 17
Tannic Acid Attenuates Peripheral and Brain Changes in a Preclinical Rat Model of Glioblastoma by Modulating Oxidative Stress and Purinergic Signaling
Natália Pontes Bona, Mayara Sandrielly Pereira Soares, Nathália Stark Pedra, et al.
Neurochemical Research (2022) Vol. 47, Iss. 6, pp. 1541-1552
Closed Access | Times Cited: 11
Impact of gallic acid on tumor suppression: Modulation of redox homeostasis and purinergic response in in vitro and a preclinical glioblastoma model
Nathália Stark Pedra, Natália Pontes Bona, Mayara Sandrielly Pereira Soares, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 110, pp. 109156-109156
Closed Access | Times Cited: 11
Rosmarinic acid modulates purinergic signaling and induces apoptosis in melanoma cells
Gilnei Bruno da Silva, Daiane Manica, Paula Dallagnol, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 2
High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome
Deborah Pietrobono, Chiara Giacomelli, Laura Marchetti, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7706-7706
Open Access | Times Cited: 17
Influence of NSAIDs and methotrexate on CD73 expression and glioma cell growth
Daniela Vasconcelos Lopes, Amanda de Fraga Dias, Luiz Fernando Lopes Silva, et al.
Purinergic Signalling (2021) Vol. 17, Iss. 2, pp. 273-284
Open Access | Times Cited: 13

Scroll to top